The Changes of Serum Inflammatory Cytokines in Patients with Hemiplegia after Ischemic Stroke and the rehabilitation effects
TNF-α, hs-CRP, IL-6, IL-18 in Hemiplegic Patients
Abstract
Introduction: The aim of this article was to explore the rehabilitation effects of early precision exercise rehabilitation on patients with hemiplegia due to acute ischemic stroke (AIS) and its effect in improving neurological function, motor ability, and self-care in daily life and to assess the impact of early treatment on the levels of patients’ inflammatory factors (such as TNF-α, hs-CRP, IL-6, IL-18), to further understand its potential mechanisms on neural repair and rehabilitation outcomes
Material and Method: A retrospective inclusion of 230 patients with hemiplegia due to AIS was conducted, and the patients were grouped: early group (EG, 132 cases) and conventional group (CG, 98 cases) based on different treatment plans. The EG received an early exercise rehabilitation training program; the CG received traditional rehabilitation training. The effectiveness before and after treatment was assessed by the national institutes of health stroke scale (NIHSS) scoring, Wisconsin gait scale (WGS) scoring, activities of daily living (ADL) scoring, joint and muscle function indicators, and serum inflammatory factors.
Result: The EG suggested visibly better NIHSS scoring, WGS scoring, ADL scoring, walking frequency, walking speed, and joint mobility following interference compared to the CG; no visible distinction was noted in the serum inflammatory factor levels of the subjects before intervention (P >0.05). Following interference, the serum inflammatory factor levels in the EG were obviously lower as against the CG (P <0.05).
Conclusion: Early precision exercise rehabilitation can visibly improve the neurological function, motor ability, and self-care ability of patients with hemiplegia due to AIS and effectively suppress inflammatory responses, promoting neural repair.
References
Chai, Z., Zheng, J. and Shen, J., 2024. Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke. CNS Neurosci. Ther., 30(7): e14865. https://doi.org/10.1111/cns.14865
Chen, H., Lee, J.S., Michel, P., Yan, B. and Chaturvedi, S., 2024. Endovascular stroke thrombectomy for patients with large ischemic core: A review. JAMA Neurol., 81(10): 1085-1093. https://doi.org/10.1001/jamaneurol.2024.2500
Cui, P., Hou, H., Song, B., Xia, Z. and Xu, Y., 2024. Vitamin D and ischemic stroke - Association, mechanisms, and therapeutics. Ageing Res. Rev., 96: 102244. https://doi.org/10.1016/j.arr.2024.102244
DeLong, J.H., Ohashi, S.N., O'Connor, K.C. and Sansing, L.H., 2022. Inflammatory responses after ischemic stroke. Semin. Immunopathol., 44(5): 625-648. https://doi.org/10.1007/s00281-022-00943-7
Franx, B., Dijkhuizen, R.M. and Dippel, D.W.J., 2024. Acute ischemic stroke in the clinic and the laboratory: Targets for translational research. Neuroscience, 550: 114-124. https://doi.org/10.1016/j.neuroscience.2024.04.006
Ho, C.C., Naresh, K., Liu, Y., Wu, Y., Gopal, A.K. and Eckel, A.M., 2024. Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression. Cancer Genet., 284-285: 30-33. https://doi.org/10.1016/j.cancergen.2024.03.001
Li, L., Shi, C., Dong, F., Xu, G., Lei, M. and Zhang, F., 2024. Targeting pyroptosis to treat ischemic stroke: From molecular pathways to treatment strategy. Int. Immunopharmacol., 133: 112168. https://doi.org/10.1016/j.intimp.2024.112168
Liu, H. and Tang, T., 2023. A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value. Am. J. Transl. Res., 15(3): 2140-2155.
Liu, H. and Tang, T., 2022. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front. Oncol., 12:952290. https://doi.org/10.3389/fonc.2022.952290
Lu, W., Wang, Y. and Wen, J., 2024. The roles of RhoA/ROCK/NF-κB pathway in microglia polarization following ischemic stroke. J. Neuroimmune Pharmacol., 19(1): 19. https://doi.org/10.1007/s11481-024-10118-w
Rundblad, L.I.S., Iversen, H.K. and West, A.S., 2023. Pleocytosis in cerebrospinal fluid attributed to ischemic stroke: A review of the literature. J. Neurol. Sci., 449: 120664. https://doi.org/10.1016/j.jns.2023.120664
Sun, F., Zhou, J., Chen, X., Yang, T., Wang, G., Ge, J., Zhang, Z. and Mei, Z., 2024. No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies. J. Cereb. Blood Flow Metab., 44(6): 857-880. https://doi.org/10.1177/0271678X241237159
Sun, L.R. and Lynch, J.K., 2023. Advances in the diagnosis and treatment of pediatric arterial ischemic stroke. Neurotherapeutics, 20(3): 633-654. https://doi.org/10.1007/s13311-023-01373-5
Václavík, D., Volný, O., Cimflová, P., Švub, K., Dvorníková, K. and Bar, M., 2022. The importance of CT perfusion for diagnosis and treatment of ischemic stroke in anterior circulation. J. Integr. Neurosci., 21(3): 92. https://doi.org/10.31083/j.jin2103092
Xiaoqing, S., Yinghua, C. and Xingxing, Y., 2023. The autophagy in ischemic stroke: A regulatory role of non-coding-RNAs. Cell Signal., 104: 110586. https://doi.org/10.1016/j.cellsig.2022.110586
Xu, G., Liu, G., Wang, Z., Li, Y. and Fang, W., 2023. Circular RNAs: Promising treatment targets and biomarkers of ischemic stroke. Int. J. Mol. Sci., 25(1): 178. https://doi.org/ 10.3390/ijms25010178
Zhang, J., Ling, L., Xiang, L., Li, W., Bao, P. and Yue, W., 2024. Role of the gut microbiota in complications after ischemic stroke. Front. Cell. Infect. Microbiol., 14: 1334581. https://doi.org/10.3389/fcimb.2024.1334581
Zheng, K., Lin, L., Jiang, W., Chen, L., Zhang, X., Zhang, Q., Ren, Y. and Hao, J., 2022. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J. Cereb. Blood Flow Metab., 42(1): 56-73. https://doi.org/10.1177/0271678X211026770
Zheng, Y., Gu, H. and Kong, Y., 2025. Targeting PTEN in ischemic stroke: From molecular mechanisms to therapeutic potentials. Exp. Neurol., 383: 115023. https://doi.org/10.1016/j.expneurol.2024.115023
Copyright (c) 2025 Yunqi Lai
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.